Indraprastha Medical Corporation Share Price

Indrapr.Medical Corporate Action

CMP as on 06-Oct-22 15:52

₹ 62.00
0.55 0.9%

Open

₹ 62.20

Turnover (lac)

₹ 73

Prev. Close

₹ 61.45

Day's Vol (shares)

₹ 1,17,016

Day's Range (₹)

₹ 61.60
₹ 62.90

CMP as on06-Oct-22 15:29

₹ 61.80
0.4 0.65%

Open

₹ 60.90

Turnover (lac)

₹ 1

Prev. Close

₹ 61.40

Day's Vol (shares)

₹ 6,887

Day's Range

₹ 60.90
₹ 62.80

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 29-Jul-2022 - -
INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2022 inter alia to consider and approve the unaudited financial results for the quarter ended 30th June 2022 This is to inform that the Board of Directors of the Company has, at its meeting held on Monday, 8th August, 2022 (i.e. today), inter-alia, considered and approved the following items: 1. Considered and approved the Un-audited Financial Results for the quarter ended 30th June, 2022, along with the Limited Review Report of the statutory auditor. 2. Approved convening the thirty-fourth Annual General Meeting (AGM) of the Company, on Friday, 23rd September, 2022, through video conferencing and other audio visual means. 3. The Register of Members and Share Transfer Books of the Company shall remain closed from Saturday, 17th September, 2022 to Friday, 23rd September, 2022 (both days inclusive) for the purpose of the AGM and declaration of dividend. The Board meeting commenced at 3.00 p.m. and ended at 5.20 p.m. (As Per BSE Announcement Dated on 08.08.2022)
Board Meeting - 11-May-2022 - -
Indraprastha Medical Corporation Limited has informed the Exchange about Board Meeting to be held on 20-May-2022 to consider financial statements for the period ended March 2022 and Dividend 1. Approved the Audited Financial Statements for the year ended 31st March, 2022 and Audited Financial Results for the quarter/year ended 31st March, 2022, as recommended by the Audit Committee; 2. Recommended a dividend @ 25% i.e. Rs. 2.50 per share for the financial year 2021-22.; and 3. Re-appointed, based on the recommendation of the Audit Committee, S. N. Dhawan & Co LLP, Chartered Accountants (Firm Reg. No. 000050N/N500045) as the Statutory Auditors of the Company for the second term of 5 years i.e. from the conclusion of the thirty-fourth Annual General Meeting (AGM) of the Company to be held in September, 2022 up to the conclusion of the thirty-ninth AGM of the Company to be held in the year 2027, subject to approval of the shareholders of the Company. (As per BSE Announcement Dated on 20/05/2022)
Board Meeting - 29-Jan-2022 - -
INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday 8th February 2022 inter-alia to consider and approve the unaudited financial results for the quarter and nine months ended 31st December 2021. This is for your information and record. The Board of Directors of the Company, at their meeting held on 8th February, 2022, have approved the Unaudited Financial Results for the quarter and nine months ended 31st December, 2021. We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and nine months ended 31st December, 2021, along with a copy of the Limited Review Report by the Auditors. The Board meeting started at 3.00 p.m. and ended at 5.55 p.m. (As per BSE Announcement Dated on 08/02/2022)
Board Meeting - 01-Nov-2021 - -
Quarterly Results INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday, 9th November, 2021, to consider and approve, the unaudited financial results for the quarter and half year ended 30th September, 2021. The Board of Directors of the Company, at their meeting held on 9th November, 2021, have, inter alia, approved the Unaudited Financial Results for the quarter and half year ended 30th September, 2021. We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and half year ended 30th September, 2021, along with a copy of the Limited Review Report by the Auditors. The Board meeting started at 3.00 p.m. and ended at 5.05 p.m. This is for your information and record. (As Per BSE Announcement dated on 09.11.2021)
Open ZERO Brokerage Demat Account Open Demat Account
  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity